Data from EPG Health Media - Curated by Toby Galbraith - Last updated 21 July 2017

Browse related ATC

ANTIINFECTIVES FOR SYSTEMIC USE
ANTIVIRALS FOR SYSTEMIC USE
DIRECT ACTING ANTIVIRALS
Non-nucleoside reverse transcriptase inhibitors
Nucleoside and nucleotide reverse transcriptase inhibitors
Phosphonic acid derivatives
Other antivirals
Thiosemicarbazones
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Antivirals for treatment of HIV infections, combinations
Neuraminidase inhibitors
Cyclic amines
Protease inhibitors

Drug

Foscavir (FOSCARNET SODIUM)

ATC
Orphan drug
No

Updated 3 months ago

Tivicay (DOLUTEGRAVIR SODIUM)

ATC
Orphan drug
No

Updated 4 months ago

DAKLINZA (DACLATASVIR)

ATC
Orphan drug
No

Updated 3 months ago

Abacavir and Lamivudine (ABACAVIR SULFATE AND LAMIVUDINE)

ATC
Orphan drug
No

Updated 2 months ago

FUZEON (ENFUVIRTIDE)

ATC
Orphan drug
No

Updated 6 months ago

Moderiba (RIBAVIRIN)

ATC
Orphan drug
No

Updated 4 months ago

Triumeq (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE)

ATC
Orphan drug
No

Updated 3 months ago

Sovaldi (SOFOSBUVIR)

ATC
Orphan drug
No

Updated 3 months ago

VIDEX (DIDANOSINE)

ATC
Orphan drug
No

Updated 5 months ago

Vitekta (ELVITEGRAVIR)

ATC
Orphan drug
No

Updated 5 months ago